Fosun Tourism’s post-Covid holiday fizzles
The resort unit of one of China’s leading conglomerates posted modest growth in the first quarter, as its broader outlook was clouded by debt issues at its parent Key Takeaways:…
Fosun International on cusp of new ‘asset-light’ era with latest sale
The conglomerate is selling its stake in multinational insurer Ageas, extending a slimming exercise touched off by a liquidity crisis in 2022 Key Takeaways: Fosun International’s total debt-to-capitalization ratio stood…
Fosun Tourism at crossroads as parent shops its two major assets
Fosun International is reportedly looking to sell some or all of its tourism unit’s Atlantis Sanya mega-resort, as well as a stake in the unit’s Club Med resort chain Key…
Fosun Tourism embarks on new journey with departure of big-name director
Henri Giscard d’Estaing has left the board of Fosun Tourism, which is refocusing on China and Southeast Asia, to ‘devote additional time and attention’ to his role leading Club Med…
CHINA BULLETIN: Next Stop, Deflation
In this week’s issue China slips into deflation, Chinese tour groups return to U.S. and a major property developer defaults. On a scale of 1 to 100, we give the…
Fosun Tourism rides Club Med rebound into bumper profits
The global resort operator’s business volume rose 24% in the first half of the year, while its profit more than doubled Key Takeaways: Fosun Tourism’s business volume rose 24% in…
Trip.com sees clearer skies ahead – but investors already knew that
China’s largest online travel agent’s revenue rose 7% in the fourth quarter on rebounding Asian demand, as analysts forecast growth accelerating ot 50% this year Key Takeways: Trip.com’s revenue rose…
Recent Articles
RELATED ARTICLES
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Fosun Tourism rides Club Med rebound into bumper profits
1992.HK
-
Fosun International on cusp of new ‘asset-light’ era with latest sale
0656.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
- CHINA BULLETIN: Next Stop, Deflation
-
Tongcheng flies high on post-Covid domestic travel boom
0780.HK
